| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.048 | 0.8 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.8 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.045 | 0.8 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |